Article
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
The oncologist - 8 Jun 2022
Mack Philip C, Klein Michael I, Ayers Kristin L, Zhou Xiang, Guin Sunny, Fink Marc, Rossi Michael, Ai-Kateb Hussam, O'Connell Timmy, Hantash Feras M, Oh William K, Newman Scott, Schadt Eric E, Chen Rong, Hirsch Fred R
Abstract excerpt
INTRODUCTION: Historically, high rates of actionable driver mutations have been reported in never-smokers with lung adenocarcinoma (ADC). In the era of modern, comprehensive cancer mutation sequencing, this relationship necessitates a more detailed analysis. METHODS: All Mount Sinai patients betw...
Topics
- Adenocarcinoma of Lung
- Female
- High-Throughput Nucleotide Sequencing
- Humans
- Lung Neoplasms
- Mutation
- Proto-Oncogene Proteins
- Proto-Oncogene Proteins p21(ras)
- Smokers
